Could a rheumatoid arthritis drug help heal traumatic brain injuries?
NCT ID NCT06065046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether baricitinib, a drug used for arthritis, can help people recover from moderate to severe traumatic brain injuries that involve bleeding in the brain. About 100 adults will receive the drug or a placebo within 24 hours of injury. The main goal is to see if it improves long-term function and reduces inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tandu Hospital, Fourth Military Medical University
RECRUITINGXi'an, Shaanxi, 710038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?